Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2487157rdf:typepubmed:Citationlld:pubmed
pubmed-article:2487157lifeskim:mentionsumls-concept:C0010631lld:lifeskim
pubmed-article:2487157lifeskim:mentionsumls-concept:C0205065lld:lifeskim
pubmed-article:2487157lifeskim:mentionsumls-concept:C1520354lld:lifeskim
pubmed-article:2487157lifeskim:mentionsumls-concept:C1520839lld:lifeskim
pubmed-article:2487157lifeskim:mentionsumls-concept:C2745955lld:lifeskim
pubmed-article:2487157lifeskim:mentionsumls-concept:C2919537lld:lifeskim
pubmed-article:2487157lifeskim:mentionsumls-concept:C0520510lld:lifeskim
pubmed-article:2487157lifeskim:mentionsumls-concept:C0332290lld:lifeskim
pubmed-article:2487157lifeskim:mentionsumls-concept:C1517945lld:lifeskim
pubmed-article:2487157lifeskim:mentionsumls-concept:C1553568lld:lifeskim
pubmed-article:2487157lifeskim:mentionsumls-concept:C1553592lld:lifeskim
pubmed-article:2487157pubmed:issue2lld:pubmed
pubmed-article:2487157pubmed:dateCreated1991-3-14lld:pubmed
pubmed-article:2487157pubmed:abstractTextCytogenetic analysis of short-term cultures from 11 moderately to poorly differentiated ovarian seropapillary cystadenocarcinomas revealed clonal chromosomal abnormalities in nine tumors. Two bands were involved in structural rearrangements in more than half of the tumors. The band most frequently affected was 19p13; rearrangements giving rise to a 19p+ marker chromosome were found in seven tumors, and in four of them the 19p+ markers appeared to be identical. Structural rearrangements resulting in loss of 11p13-11pter material were found in six tumors.lld:pubmed
pubmed-article:2487157pubmed:languageenglld:pubmed
pubmed-article:2487157pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2487157pubmed:citationSubsetIMlld:pubmed
pubmed-article:2487157pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2487157pubmed:statusMEDLINElld:pubmed
pubmed-article:2487157pubmed:monthNovlld:pubmed
pubmed-article:2487157pubmed:issn1045-2257lld:pubmed
pubmed-article:2487157pubmed:authorpubmed-author:MitelmanFFlld:pubmed
pubmed-article:2487157pubmed:authorpubmed-author:HeldLLlld:pubmed
pubmed-article:2487157pubmed:authorpubmed-author:MandahlNNlld:pubmed
pubmed-article:2487157pubmed:authorpubmed-author:WillénHHlld:pubmed
pubmed-article:2487157pubmed:authorpubmed-author:HeinPPlld:pubmed
pubmed-article:2487157pubmed:authorpubmed-author:ElmforsBBlld:pubmed
pubmed-article:2487157pubmed:authorpubmed-author:FurgyikSSlld:pubmed
pubmed-article:2487157pubmed:authorpubmed-author:FlodérusU MUMlld:pubmed
pubmed-article:2487157pubmed:authorpubmed-author:PejovicTTlld:pubmed
pubmed-article:2487157pubmed:issnTypePrintlld:pubmed
pubmed-article:2487157pubmed:volume1lld:pubmed
pubmed-article:2487157pubmed:ownerNLMlld:pubmed
pubmed-article:2487157pubmed:authorsCompleteYlld:pubmed
pubmed-article:2487157pubmed:pagination167-71lld:pubmed
pubmed-article:2487157pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2487157pubmed:meshHeadingpubmed-meshheading:2487157-...lld:pubmed
pubmed-article:2487157pubmed:meshHeadingpubmed-meshheading:2487157-...lld:pubmed
pubmed-article:2487157pubmed:meshHeadingpubmed-meshheading:2487157-...lld:pubmed
pubmed-article:2487157pubmed:meshHeadingpubmed-meshheading:2487157-...lld:pubmed
pubmed-article:2487157pubmed:meshHeadingpubmed-meshheading:2487157-...lld:pubmed
pubmed-article:2487157pubmed:meshHeadingpubmed-meshheading:2487157-...lld:pubmed
pubmed-article:2487157pubmed:meshHeadingpubmed-meshheading:2487157-...lld:pubmed
pubmed-article:2487157pubmed:meshHeadingpubmed-meshheading:2487157-...lld:pubmed
pubmed-article:2487157pubmed:meshHeadingpubmed-meshheading:2487157-...lld:pubmed
pubmed-article:2487157pubmed:meshHeadingpubmed-meshheading:2487157-...lld:pubmed
pubmed-article:2487157pubmed:meshHeadingpubmed-meshheading:2487157-...lld:pubmed
pubmed-article:2487157pubmed:meshHeadingpubmed-meshheading:2487157-...lld:pubmed
pubmed-article:2487157pubmed:meshHeadingpubmed-meshheading:2487157-...lld:pubmed
pubmed-article:2487157pubmed:meshHeadingpubmed-meshheading:2487157-...lld:pubmed
pubmed-article:2487157pubmed:meshHeadingpubmed-meshheading:2487157-...lld:pubmed
pubmed-article:2487157pubmed:meshHeadingpubmed-meshheading:2487157-...lld:pubmed
pubmed-article:2487157pubmed:year1989lld:pubmed
pubmed-article:2487157pubmed:articleTitleConsistent occurrence of a 19p+ marker chromosome and loss of 11p material in ovarian seropapillary cystadenocarcinomas.lld:pubmed
pubmed-article:2487157pubmed:affiliationDepartment of Clinical Genetics, University Hospital, Lund, Sweden.lld:pubmed
pubmed-article:2487157pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2487157pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2487157lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2487157lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2487157lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2487157lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2487157lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2487157lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2487157lld:pubmed